| PERIOD ENDING | 21-Mar-09 | 27-Dec-08 | 6-Sep-08 | 14-Jun-08 | | Total Revenue | 2,507,000 | 3,809,000 | 3,814,000 | 3,522,000 | | Cost of Revenue | 1,403,000 | 2,111,000 | 2,077,000 | 1,916,000 | | | Gross Profit | 1,104,000 | 1,698,000 | 1,737,000 | 1,606,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 987,000 | 1,550,000 | 1,282,000 | 1,256,000 | | Non Recurring |
-
| 412,000 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 117,000 | (264,000) | 455,000 | 350,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (7,000) | (26,000) | (5,000) | 3,000 | | Earnings Before Interest And Taxes | 110,000 | (274,000) | 407,000 | 323,000 | | Interest Expense | 79,000 | 103,000 | 65,000 | 63,000 | | Income Before Tax | 31,000 | (377,000) | 342,000 | 260,000 | | Income Tax Expense | (27,000) | (106,000) | 111,000 | 86,000 | | Minority Interest |
-
| 16,000 | (43,000) | (30,000) | | | | Net Income From Continuing Ops | 58,000 | (271,000) | 231,000 | 174,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 58,000 | (271,000) | 231,000 | 174,000 | | Preferred Stock And Other Adjustments | (1,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $57,000 | ($271,000) | $231,000 | $174,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
